Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion

World Journal of Gastroenterology

Volumn 12, Issue 20, 2006, Pages 3288-3291

  Wang, Tao ^a   Tian, Fu Zhou ^a   Cai, Zhong Hong ^a   Li, Xu ^a   Cheng, Tao ^a   Shi, Li ^a   Cheng, Qi ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Analgesia; Celiac ganglion; Chemical destruction; Pancreatic carcinoma; Ultrasonic intervention

Indexed keywords

ALCOHOL; BETA ENDORPHIN; SUBSTANCE P;

ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; B SCAN; CANCER PAIN; CELIAC ARTERY; CELIAC GANGLION; CELLULAR IMMUNITY; COLON CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTRACTABLE PAIN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROLYSIS; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREAS SURGERY; PANCREATITIS; PERITONITIS; PUNCTURE; RECURRENCE RISK; SAFETY; SPINAL CORD METASTASIS; T LYMPHOCYTE SUBPOPULATION; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 33745112120     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i20.3288     Document Type: Article

References (13)

1. Howard JM, Jordan GL, Reber HA. Surgical diseases of the pancreas. LEA&FEBIGER Philadelphia: 1987: 33-34
2. Kelsen DP, Portenoy R, Thaler H, Tao Y, Brennan M. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997; 122: 53-59
3. McCleane GJ. Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma. Pain 1997; 73:263-264
4. Kar S, Rees RG, Quirion R. Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat. Eur J Neurosci 1994; 6: 345-354
5. Milian MJ. Multiple opioid systems and pain. Pain 1986; 27: 303-347
6. Melzack R, Wall PD. The challenge of pain. Basic Books Inc, 1983: 374-376
7. Ma ZL, Fan SH, Guo NZ, Sheng YF, He FX. Clinical study on the relationship between cancer pain and immune level. Zhongguo Tengtong Yixue Zazhi 1999; 5: 133-135
8. McDonough RJ, Madden JJ, Falek A, Shafer DA, Pline M, Gordon D, Bokos P, Kuehnle JC, Mendelson J. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 1980; 125: 2539-2543
9. Bryant HU, Bernton EW, Holaday JW. Morphine pellet-induced immunomodulation in mice: temporal relationships. J Phartnacol Exp Ther 1988; 245: 913-920
10. Sei Y, Yoshimoto K, McIntyre T, Skolnick P, Arora PK. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J Immunol 1991; 146:194-198
11. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schafer M, Loeffler JP, Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 1997; 100: 142-148
12. Mandler RN, Biddison WE, Mandler R, Serrate SA. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 1986; 136: 934-939
13. Brown SL, Van Epps DE. Opioid peptides modulate production of interferon gamma by human mononuclear cells. Cell Immunol 1986; 103:19-26